Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, par value US$0.0001 per share
-
Shares outstanding
-
37,387,057
-
Total 13F shares
-
149,657
-
Share change
-
-130,299
-
Total reported value
-
$9,909,658
-
Price per share
-
$66.22
-
Number of holders
-
18
-
Value change
-
-$8,038,751
-
Number of buys
-
12
-
Number of sells
-
14
Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q1 2025
As of 31 Mar 2025,
BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
149,657 shares.
The largest 10 holders included
Alyeska Investment Group, L.P., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, HRT FINANCIAL LP, AMERIPRISE FINANCIAL INC, Virtus Investment Advisers, LLC, and GAMMA Investing LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.